Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BLC661

Bladder cancer tissue array, 33 cases/66 cores
Unstained: $170.00 Add to Cart
H&E (BLC661s*): $170.00 Add to Cart

Microarray Panel:Bladder cancer tissue array, 66 cores including 29 cases of bladder cancers and 4 uninvolved bladder tissues in duplicates
Cores:66
Cases:33
Layout:9 cols × 8 rows
Core Diameter:1.5 mm
Thickness:4 µm
Quality Control:H&E, IHC anti-Vimentin/Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789
A Bla Bla Bla Bla Bla Bla Bla Bla Bla
B Bla Bla Bla Bla Bla Bla Bla Bla Bla
C Bla Bla Bla Bla Bla Bla Bla Bla Bla
D Bla Bla Bla Bla Bla Bla Bla Bla Bla
E Bla Bla Bla Bla Bla Bla Bla Bla Bla
F Bla Bla Bla Bla Bla Bla Bla Bla Bla
G Bla Bla Bla Bla Bla Bla Bla Bla Bla
H Bla Bla Bla
Legend: Bla - Bladder

- Inflammation, - Malignant tumor, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 71 M Bladder Normal Normal
A2 2 59 M Bladder Normal Normal
A3 3 65 M Bladder Chronic cystitis Inflammation
A4 4 51 F Bladder Chronic cystitis Inflammation
A5 5 71 M Bladder Squamous cell carcinoma I~II T1N0M0 Malignant
A6 6 60 M Bladder Squamous cell carcinoma I T2N0M0 Malignant
A7 7 76 M Bladder Adenocarcinoma I~II T2N0M0 Malignant
A8 8 50 M Bladder Adenocarcinoma II T2N0M0 Malignant
A9 9 68 M Bladder Adenocarcinoma III T2N0M0 Malignant
B1 10 71 M Bladder Normal Normal
B2 11 59 M Bladder Normal Normal
B3 12 65 M Bladder Chronic cystitis Inflammation
B4 13 51 F Bladder Chronic cystitis Inflammation
B5 14 71 M Bladder Squamous cell carcinoma I~II T1N0M0 Malignant
B6 15 60 M Bladder Squamous cell carcinoma I T2N0M0 Malignant
B7 16 76 M Bladder Adenocarcinoma I~II T2N0M0 Malignant
B8 17 50 M Bladder Adenocarcinoma II T2N0M0 Malignant
B9 18 68 M Bladder Adenocarcinoma III T2N0M0 Malignant
C1 19 74 F Bladder Adenocarcinoma III T2N0M0 Malignant
C2 20 27 M Bladder Transitional cell carcinoma I TisN0M0 Malignant
C3 21 50 M Bladder Transitional cell carcinoma I T1N0M0 Malignant
C4 22 49 F Bladder Transitional cell carcinoma I T1N0M0 Malignant
C5 23 67 M Bladder Transitional cell carcinoma I T1N0M0 Malignant
C6 24 51 F Bladder Transitional cell carcinoma II T1N0M0 Malignant
C7 25 57 M Bladder Transitional cell carcinoma I T1N0M0 Malignant
C8 26 47 M Bladder Transitional cell carcinoma I~II T2N0M0 Malignant
C9 27 54 M Bladder Transitional cell carcinoma II T2N0M0 Malignant
D1 28 74 F Bladder Adenocarcinoma III T2N0M0 Malignant
D2 29 27 M Bladder Transitional cell carcinoma I TisN0M0 Malignant
D3 30 50 M Bladder Transitional cell carcinoma I T1N0M0 Malignant
D4 31 49 F Bladder Transitional cell carcinoma I T1N0M0 Malignant
D5 32 67 M Bladder Transitional cell carcinoma I T1N0M0 Malignant
D6 33 51 F Bladder Transitional cell carcinoma II T1N0M0 Malignant
D7 34 57 M Bladder Transitional cell carcinoma I T1N0M0 Malignant
D8 35 47 M Bladder Transitional cell carcinoma I~II T2N0M0 Malignant
D9 36 54 M Bladder Transitional cell carcinoma II T2N0M0 Malignant
E1 37 45 M Bladder Transitional cell carcinoma II T1N0M0 Malignant
E2 38 74 M Bladder Transitional cell carcinoma II T2N0M0 Malignant
E3 39 51 M Bladder Transitional cell carcinoma II T1N0M0 Malignant
E4 40 80 M Bladder Transitional cell carcinoma II~III T2N0M0 Malignant
E5 41 53 F Bladder Transitional cell carcinoma I~II T1N0M0 Malignant
E6 42 37 M Bladder Transitional cell carcinoma III T2N0M0 Malignant
E7 43 55 M Bladder Transitional cell carcinoma I~II T4N2MX Malignant
E8 44 52 M Bladder Transitional cell carcinoma II T1N0M0 Malignant
E9 45 78 M Bladder Transitional cell carcinoma II~III T1N0M0 Malignant
F1 46 45 M Bladder Transitional cell carcinoma II T1N0M0 Malignant
F2 47 74 M Bladder Transitional cell carcinoma II T2N0M0 Malignant
F3 48 51 M Bladder Transitional cell carcinoma II T1N0M0 Malignant
F4 49 80 M Bladder Transitional cell carcinoma II~III T2N0M0 Malignant
F5 50 53 F Bladder Transitional cell carcinoma I~II T1N0M0 Malignant
F6 51 37 M Bladder Transitional cell carcinoma III T2N0M0 Malignant
F7 52 55 M Bladder Transitional cell carcinoma I~II T4N2MX Malignant
F8 53 52 M Bladder Transitional cell carcinoma II T1N0M0 Malignant
F9 54 78 M Bladder Transitional cell carcinoma II~III T1N0M0 Malignant
G1 55 64 M Bladder Transitional cell carcinoma III T3N2M1 Malignant
G2 56 70 M Bladder Transitional cell carcinoma III T2N0M0 Malignant
G3 57 61 M Bladder Transitional cell carcinoma III T2N0M0 Malignant
G4 58 61 M Bladder Transitional cell carcinoma III T1N0M0 Malignant
G5 59 39 F Bladder Transitional cell carcinoma III T2N0M0 Malignant
G6 60 30 M Bladder Sarcoma T2N0M0 Malignant
G7 61 64 M Bladder Transitional cell carcinoma III T3N2M1 Malignant
G8 62 70 M Bladder Transitional cell carcinoma III T2N0M0 Malignant
G9 63 61 M Bladder Transitional cell carcinoma III T2N0M0 Malignant
H1 64 61 M Bladder Transitional cell carcinoma III T1N0M0 Malignant
H2 65 39 F Bladder Transitional cell carcinoma III T2N0M0 Malignant
H3 66 30 M Bladder Sarcoma T2N0M0 Malignant


† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Sorry, this tissue array cannot be compared to find overlapping cases.
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal